AmBisome liposomale amfotericine B 50 mg, poeder voor dispersie voor infusie הולנד - הולנדית - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

ambisome liposomale amfotericine b 50 mg, poeder voor dispersie voor infusie

bmodesto b.v. minervaweg 2 8239 dl lelystad - amfotericine b - poeder voor dispersie voor infusie - cholesterol ; dinatriumsuccinaat 6-water ; distearoylfosfatidylglycerol ; fosfatidylcholine, soja, gehydreerd ; natriumhydroxide (e 524) ; saccharose ; tocoferol, dl-alfa (e 307) ; zoutzuur (e 507)

Tecartus האיחוד האירופי - הולנדית - EMA (European Medicines Agency)

tecartus

kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - lymfoom, mantel-cel - antineoplastische middelen - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).